Randall Moreadith - Jul 21, 2025 Form 4 Insider Report for Serina Therapeutics, Inc. (SER)

Role
Chief Scientific Officer
Signature
/s/ Randall Moreadith
Stock symbol
SER
Transactions as of
Jul 21, 2025
Transactions value $
-$34,320
Form type
4
Date filed
7/22/2025, 10:25 AM
Previous filing
Jul 17, 2025
Next filing
Jul 29, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Moreadith Randall Chief Scientific Officer 601 GENOME WAY, SUITE 2001, HUNTSVILLE /s/ Randall Moreadith 2025-07-22 0001301120

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SER Common Stock Options Exercise $390 +6.5K $0.06 6.5K Jul 21, 2025 Direct
transaction SER Common Stock Sale -$34.7K -6.5K -100% $5.34 0 Jul 21, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SER Stock Option (right to buy) Options Exercise $0 -6.5K -1.3% $0.00 495K Jul 21, 2025 Common Stock 6.5K $0.06 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.31 to $5.40. The reporting person undertakes to provide to Serina Therapeutics, Inc., any security holder of Serina Therapeutis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
F2 The stock options are fully vested.